Atypical Antipsychotic-Induced Parkinsonism: A Patient Case with CYP Enzyme Implications
Objective: To report a case of Parkinsonism potentially caused by neuroleptic medications. Summary: The case analyzed is that of a 57-year-old male patient referred to a pharmacotherapy service by a neurologist after organic causes of tremor had been ruled out. Iatrogenic cause was suspected and...
Main Authors: | Carla Dolci Figura, Michael Schuh |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2017-04-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/507 |
Similar Items
-
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
by: Feldman M, et al.
Published: (2022-12-01) -
Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01) -
Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report
by: Alexey A. Tappakhov, et al.
Published: (2020-06-01) -
Electroconvulsive Therapy as a Corrector for Certain Side Effects of Antipsychotic Therapy
by: Yu. V. Bykov, et al.
Published: (2020-05-01) -
Parkinson’s Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism
by: Ivan Kotomin, et al.
Published: (2022-12-01)